Q Bio, Inc.

The prostate-specific antigen (PSA) test is the front-line clinical test for telling men whether they likely have prosta...

a16zActive

What they do

Problem

The standard PSA blood test for prostate cancer screening produces many inaccurate results, leading to unnecessary biopsies and missed or delayed diagnoses.

Solution

Q Bio develops improved prostate cancer diagnostic tests/biomarker assays intended to provide more accurate screening than PSA alone.

Who it's for

Clinical labs and healthcare providers (urologists and hospitals) who screen and evaluate men for prostate cancer.

Company timeline

StatusActive

Similar startups

Signatur Biosciences

Simple tests for complex diseases.

Tuli Health

Transforming pharmacies in the UK into diagnostic centers

Spot Health

At-home diagnostics as a service

Orange Health Labs

India's Fastest Diagnostics Service

Redcliffe Lifetech

Redcliffe Labs is India's Largest Omni-channel Diagnostics platform

Coral Genomics

New clinical tests for managing autoimmune treatments.